title: Multiple conformational states of the bacteriophage T4 capsid surface lattice induced when expansion occurs without prior cleavage.
abstract: The maturation pathway of bacteriophage T4 capsid provides a model system for the study of largescale conformational changes, in that the precursor capsid progresses through four long-lived and widely differing states. The surface lattice first assembled (uncleaved/unexpanded state: hexagonal lattice constant, a = 11.8 nm) undergoes proteolytic cleavage (cleaved/unexpanded state), then expands (cleaved/ expanded state: a = 14.0 nm), and then binds accessory proteins. The most profound change, expansion, normally follows cleavage of the major capsid protein gp23 to gp23* (the 65-residue N-terminal "delta-domain" is removed), but can be induced in vitro in the absence of cleavage by treatment with 0.25 M guanidine-HCl (uncleaved/expanded state). We have studied this alternative pathway by negative staining electron microscopy of polyheads (tubular capsid variants). We find that uncleaved/expanded polyheads encompass four discrete states, called G1-G4, distinguished by their lattice constants of 12.6 nm (G1), 13.4 nm (G2), and 14.0 nm (G3, G4) and by the structures of their hexameric capsomers. Viewed in projection, the G4 capsomer differs from the cleaved/ expanded capsomer only in the presence of additional mass at one site per protomer. This mass correlates with the presence of the delta-domain, which translocates from the inner to the outer surface when the uncleaved lattice expands. Based on proximity of resemblance among these capsomers, we suggest that G1 to G4 represent a sequence of transitional states whose endpoint is G4. G1, G2, and G3 may correspond to intermediates that are too short-lived to be observed when the cleaved lattice expands, but are trapped by the retention of delta-domains at the interfaces between subunits in the uncleaved lattice.
authors.affiliation: Laboratory of Structural Biology, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892-2717, USA.
authors.forename: E
authors.initials: E
authors.lastname: Kocsis
authors.forename: H L
authors.initials: HL
authors.lastname: Greenstone
authors.forename: E G
authors.initials: EG
authors.lastname: Locke
authors.forename: M
authors.initials: M
authors.lastname: Kessel
authors.forename: A C
authors.initials: AC
authors.lastname: Steven
mesh_terms: D017122:Bacteriophage T4 / Q000737:chemistry*; D002213:Capsid / Q000737:chemistry* / Q000187:drug effects; D036022:Capsid Proteins; D019791:Guanidine; D006146:Guanidines / Q000494:pharmacology; D008854:Microscopy, Electron; D011487:Protein Conformation; D017510:Protein Folding
chemical_list: D036022:Capsid Proteins; D006146:Guanidines; C064517:gp23 protein, Bacteriophage T4; D019791:Guanidine